Trial Profile
A Randomized, Double Blind, Multi-center, Placebo-Controlled Exploratory Study of AS-3201 in Patients with Diabetic Sensorimotor Polyneuropathy [Phase II]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Ranirestat (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 10 Jun 2016 New trial record